Fane Mensah

Source:Twitter

Fane Mensah, PhD., studied immunology, specifically B cells and immunometabolism, in the division of Medicine at University College London, a public research university in London, England. He serves as the Head of Community at the Computer-Aided Biology Community and Scientific Community Manager at Synthace Limited, both of London, UK. He is the managing director of the Science Entrepreneur Club, a non-profit organization whose goal is to foster innovation and talent in the life science ecosystem.

Education

• 2011, BSc degree in Biology and medical research, Rotterdam University of Applied Sciences
• 2013, MSc degree in Infection and Immunity, Erasmus University Rotterdam
• 2019, PhD in Immunology, University College London

Doctorate thesis

• 2019, Title: Investigations of B cell phenotype and metabolic function in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome; awarded by UCL (University College London). - (Abstract)

Awards

• 2016 Ramsay Award Program grant recipient, sponsored by the Solve ME/CFS Initiative. This grant, shared with Geraldine Cambridge, University College London, and Christopher Armstrong, University of Melbourne, will focus on the metabolic analysis of B-Cell maturation in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Notable studies

• 2016, Extended B cell phenotype in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A cross-sectional study (Full Text)
• 2017, Review - Chronic fatigue syndrome and the immune system: Where are we now? (Abstract)
• 2018, CD24 Expression and B Cell Maturation Shows a Novel Link With Energy Metabolism: Potential Implications for Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (Full Text)

Talks and interviews

• 2017, Speaker at the 12th Invest in ME International ME Conference on "Immunoregulation in patients with ME" - DVD available
• 2018, Briefed Australia's Chief Medical Officer, Prof Brendan Murphy, on international ME research.

Online presence

• Facebook
• LinkedIn
• PubMed - Fane Mensah CFS
• ResearchGate
• Twitter

See also

• Autoimmune hypothesis
• B cell
• Geraldine Cambridge
• Invest in ME
• Jonathan Edwards
• Rituximab

Learn more

• 2014, "ME/CFS – Through The Eyes of a Young Researcher"

• 2018, 'Meet the Scientist - Fane Mensah'
• Young researchers present on the global stage

B cell B lymphocyte, or a type of white blood cell, which is involved in the immune response by secreting antibodies to ward off infections. In mammals, they are mostly matured in the bone marrow.

myalgic encephalomyelitis (M.E.) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

See myalgic encephalomyelitis.

See chronic fatigue syndrome.